To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Metro

Boston.com

Brian McGrory

Driven by loss, father inspires tireless pursuit of a cure

By Brian McGrory

 |  Globe Columnist  

  February 09, 2012

Last week, the US Food and Drug Administration issued an announcement with a title that only a federal bureaucrat could write: “FDA approves Kalydeco to treat rare form of cystic fibrosis.’’ In fact, it was a blockbuster development, the first drug that would treat the cause, rather than the symptoms, of CF, a medication that showed such breathtaking results in clinical trials that it was sanctioned by the FDA in about half the typical time. And behind that announcement sits a human narrative, a quarter century in the making, of loss, hope, and triumph.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help